ADMA Biologics Inc (NASDAQ:ADMA)

Delayed Data
As of Jul 01
 +0.05 / +2.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.50. The median estimate represents a +133.99% increase from the last price of 2.03.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.31%
Growthannually 38.24%


Growthquarterly 8.92%
Growthannually 64.75%
Key to the earnings and sales forecast charts.